Logo image of JRSH

JERASH HOLDINGS US INC (JRSH) Stock Fundamental Analysis

NASDAQ:JRSH - US47632P1012 - Common Stock

3.4 USD
+0.03 (+0.89%)
Last: 8/28/2025, 4:30:02 PM
Fundamental Rating

4

JRSH gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of JRSH is average, but there are quite some concerns on its profitability. JRSH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

JRSH had positive earnings in the past year.
In the past year JRSH had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: JRSH reported negative net income in multiple years.
JRSH had a positive operating cash flow in 4 of the past 5 years.
JRSH Yearly Net Income VS EBIT VS OCF VS FCFJRSH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M 10M

1.2 Ratios

The Return On Assets of JRSH (-1.02%) is worse than 64.00% of its industry peers.
With a Return On Equity value of -1.35%, JRSH is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
JRSH's Return On Invested Capital of 1.69% is on the low side compared to the rest of the industry. JRSH is outperformed by 74.00% of its industry peers.
Industry RankSector Rank
ROA -1.02%
ROE -1.35%
ROIC 1.69%
ROA(3y)-0.22%
ROA(5y)2.84%
ROE(3y)-0.32%
ROE(5y)3.54%
ROIC(3y)N/A
ROIC(5y)N/A
JRSH Yearly ROA, ROE, ROICJRSH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

1.3 Margins

Looking at the Operating Margin, with a value of 0.99%, JRSH is doing worse than 76.00% of the companies in the same industry.
JRSH's Operating Margin has declined in the last couple of years.
JRSH's Gross Margin of 15.31% is on the low side compared to the rest of the industry. JRSH is outperformed by 88.00% of its industry peers.
JRSH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.99%
PM (TTM) N/A
GM 15.31%
OM growth 3Y-48.63%
OM growth 5Y-34.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.01%
GM growth 5Y-4.58%
JRSH Yearly Profit, Operating, Gross MarginsJRSH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JRSH is destroying value.
JRSH has more shares outstanding than it did 1 year ago.
JRSH has more shares outstanding than it did 5 years ago.
The debt/assets ratio for JRSH is higher compared to a year ago.
JRSH Yearly Shares OutstandingJRSH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
JRSH Yearly Total Debt VS Total AssetsJRSH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

JRSH has an Altman-Z score of 4.24. This indicates that JRSH is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of JRSH (4.24) is better than 82.00% of its industry peers.
The Debt to FCF ratio of JRSH is 10.91, which is on the high side as it means it would take JRSH, 10.91 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 10.91, JRSH perfoms like the industry average, outperforming 42.00% of the companies in the same industry.
A Debt/Equity ratio of 0.07 indicates that JRSH is not too dependend on debt financing.
JRSH has a better Debt to Equity ratio (0.07) than 76.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 10.91
Altman-Z 4.24
ROIC/WACC0.14
WACC12.06%
JRSH Yearly LT Debt VS Equity VS FCFJRSH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

JRSH has a Current Ratio of 2.75. This indicates that JRSH is financially healthy and has no problem in meeting its short term obligations.
JRSH has a better Current ratio (2.75) than 78.00% of its industry peers.
A Quick Ratio of 1.35 indicates that JRSH should not have too much problems paying its short term obligations.
JRSH has a Quick ratio of 1.35. This is in the better half of the industry: JRSH outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.75
Quick Ratio 1.35
JRSH Yearly Current Assets VS Current LiabilitesJRSH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 122.58% over the past year.
The Revenue has grown by 24.43% in the past year. This is a very strong growth!
The Revenue has been growing by 9.41% on average over the past years. This is quite good.
EPS 1Y (TTM)122.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.27%
Revenue 1Y (TTM)24.43%
Revenue growth 3Y0.56%
Revenue growth 5Y9.41%
Sales Q2Q%-3.19%

3.2 Future

Based on estimates for the next years, JRSH will show a very strong growth in Earnings Per Share. The EPS will grow by 65.70% on average per year.
JRSH is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.47% yearly.
EPS Next Y442.43%
EPS Next 2Y170.53%
EPS Next 3Y117.62%
EPS Next 5Y65.7%
Revenue Next Year3.09%
Revenue Next 2Y5.69%
Revenue Next 3Y7.46%
Revenue Next 5Y8.47%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
JRSH Yearly Revenue VS EstimatesJRSH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
JRSH Yearly EPS VS EstimatesJRSH Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 48.57 indicates a quite expensive valuation of JRSH.
Compared to the rest of the industry, the Price/Earnings ratio of JRSH indicates a slightly more expensive valuation: JRSH is more expensive than 66.00% of the companies listed in the same industry.
JRSH is valuated expensively when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
JRSH is valuated reasonably with a Price/Forward Earnings ratio of 9.13.
JRSH's Price/Forward Earnings ratio is rather cheap when compared to the industry. JRSH is cheaper than 92.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of JRSH to the average of the S&P500 Index (22.78), we can say JRSH is valued rather cheaply.
Industry RankSector Rank
PE 48.57
Fwd PE 9.13
JRSH Price Earnings VS Forward Price EarningsJRSH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, JRSH is valued a bit cheaper than the industry average as 78.00% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as JRSH.
Industry RankSector Rank
P/FCF 104.43
EV/EBITDA 6.24
JRSH Per share dataJRSH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JRSH's earnings are expected to grow with 117.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.11
PEG (5Y)N/A
EPS Next 2Y170.53%
EPS Next 3Y117.62%

5

5. Dividend

5.1 Amount

JRSH has a Yearly Dividend Yield of 5.95%, which is a nice return.
Compared to an average industry Dividend Yield of 3.65, JRSH pays a better dividend. On top of this JRSH pays more dividend than 92.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, JRSH pays a better dividend.
Industry RankSector Rank
Dividend Yield 5.95%

5.2 History

The dividend of JRSH decreases each year by -1.64%.
JRSH has been paying a dividend for over 5 years, so it has already some track record.
JRSH has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-1.64%
Div Incr Years0
Div Non Decr Years6
JRSH Yearly Dividends per shareJRSH Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15

5.3 Sustainability

JRSH has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-289.87%
EPS Next 2Y170.53%
EPS Next 3Y117.62%
JRSH Yearly Income VS Free CF VS DividendJRSH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2M -2M 4M 6M 8M 10M

JERASH HOLDINGS US INC

NASDAQ:JRSH (8/28/2025, 4:30:02 PM)

3.4

+0.03 (+0.89%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)08-14 2025-08-14/bmo
Earnings (Next)11-12 2025-11-12/bmo
Inst Owners4.77%
Inst Owner Change56.01%
Ins Owners22.48%
Ins Owner Change0%
Market Cap43.18M
Analysts82.5
Price Target4.59 (35%)
Short Float %0.09%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield 5.95%
Yearly Dividend0.2
Dividend Growth(5Y)-1.64%
DP-289.87%
Div Incr Years0
Div Non Decr Years6
Ex-Date08-22 2025-08-22 (0.05)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-49.02%
Min EPS beat(2)-198.04%
Max EPS beat(2)100%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.08%
Min Revenue beat(2)-12.3%
Max Revenue beat(2)-7.86%
Revenue beat(4)2
Avg Revenue beat(4)-3.46%
Min Revenue beat(4)-12.3%
Max Revenue beat(4)5.34%
Revenue beat(8)3
Avg Revenue beat(8)-5.44%
Revenue beat(12)4
Avg Revenue beat(12)-4.13%
Revenue beat(16)7
Avg Revenue beat(16)-1.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-60%
EPS NQ rev (3m)-64.71%
EPS NY rev (1m)-11.32%
EPS NY rev (3m)-22.95%
Revenue NQ rev (1m)1.93%
Revenue NQ rev (3m)-3.41%
Revenue NY rev (1m)1.96%
Revenue NY rev (3m)-4.8%
Valuation
Industry RankSector Rank
PE 48.57
Fwd PE 9.13
P/S 0.3
P/FCF 104.43
P/OCF 31.64
P/B 0.69
P/tB 0.69
EV/EBITDA 6.24
EPS(TTM)0.07
EY2.06%
EPS(NY)0.37
Fwd EY10.95%
FCF(TTM)0.03
FCFY0.96%
OCF(TTM)0.11
OCFY3.16%
SpS11.48
BVpS4.95
TBVpS4.91
PEG (NY)0.11
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.02%
ROE -1.35%
ROCE 2.29%
ROIC 1.69%
ROICexc 2.1%
ROICexgc 2.12%
OM 0.99%
PM (TTM) N/A
GM 15.31%
FCFM 0.28%
ROA(3y)-0.22%
ROA(5y)2.84%
ROE(3y)-0.32%
ROE(5y)3.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-62.98%
ROICexcg growth 5Y-36.11%
ROICexc growth 3Y-62.79%
ROICexc growth 5Y-36.22%
OM growth 3Y-48.63%
OM growth 5Y-34.58%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.01%
GM growth 5Y-4.58%
F-Score6
Asset Turnover1.76
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 10.91
Debt/EBITDA 0.96
Cap/Depr 29.05%
Cap/Sales 0.65%
Interest Coverage 0.84
Cash Conversion 28.91%
Profit Quality N/A
Current Ratio 2.75
Quick Ratio 1.35
Altman-Z 4.24
F-Score6
WACC12.06%
ROIC/WACC0.14
Cap/Depr(3y)32.1%
Cap/Depr(5y)57.78%
Cap/Sales(3y)0.74%
Cap/Sales(5y)1.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)122.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%127.27%
EPS Next Y442.43%
EPS Next 2Y170.53%
EPS Next 3Y117.62%
EPS Next 5Y65.7%
Revenue 1Y (TTM)24.43%
Revenue growth 3Y0.56%
Revenue growth 5Y9.41%
Sales Q2Q%-3.19%
Revenue Next Year3.09%
Revenue Next 2Y5.69%
Revenue Next 3Y7.46%
Revenue Next 5Y8.47%
EBIT growth 1Y317.63%
EBIT growth 3Y-48.35%
EBIT growth 5Y-28.42%
EBIT Next Year615.39%
EBIT Next 3Y124.96%
EBIT Next 5Y69.89%
FCF growth 1Y-66.74%
FCF growth 3Y-59%
FCF growth 5Y-28.61%
OCF growth 1Y-45.08%
OCF growth 3Y-46.6%
OCF growth 5Y-27.71%